Conclusions
NOACs such as apixaban, dabigatran, darexaban, edoxaban or rivaroxaban, do not increase the risk of DILI.
Risk of Liver Injury With New Oral Anticoagulants
Risk of Liver Injury With New Oral Anticoagulants
NOACs such as apixaban, dabigatran, darexaban, edoxaban or rivaroxaban, do not increase the risk of DILI.
NOACs such as apixaban, dabigatran, darexaban, edoxaban or rivaroxaban, do not increase the risk of DILI.